By SquaredTown on September 25, 2025
TrueSite TI™, the fourth generation of WuXia™ cell line platform, leverages targeted integration technique to streamline clone screening and guarantees expression stability. The platform has achieved an average mAb titer exceeding 8.0 g/L with over 99% of clonal cell lines maintaining...